H. Furuie

发表

AJM300, a novel oral antagonist of α4‐integrin, sustains an increase in circulating lymphocytes: A randomised controlled trial in healthy male subjects

H. Fukase, T. Kajioka, Ichiro Oikawa, 2020, British journal of clinical pharmacology.

Safety and Pharmacokinetics of DS-8500a, a Novel GPR119 Agonist, After Multiple Oral Doses in Healthy Japanese Males

T. Taguchi, H. Furuie, Manabu Kato, 2018, Clinical Drug Investigation.

Analysis of Tidal Breathing in Healthy Japanese Children for Optimized Nebulizer Dosing

H. Furuie, H. Ishizuka, K. Toyama, 2018, Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics.

Single‐ and multiple‐dose escalation study to assess pharmacokinetics, pharmacodynamics and safety of oral esaxerenone in healthy Japanese subjects

Takako Shimizu, H. Furuie, Manabu Kato, 2018, British journal of clinical pharmacology.

Phase Ⅰ Clinical Trial of NE-58095 DR, a Risedronate Delayed-Release Tablet: Dose Escalation and Food Effect

H. Fukase, Ichiro Oikawa, H. Furuie, 2018, Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics.

Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers

H. Furuie, H. Kanda, 2019, Clinical Drug Investigation.

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes

T. Matsui, T. Ishizaki, H. Furuie, 2001, Alimentary pharmacology & therapeutics.

Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis.

M. Suga, M. Ando, H. Furuie, 1997, The European respiratory journal.

Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers

M. Nishimura, H. Furuie, S. Manita, 2018, Antimicrobial Agents and Chemotherapy.

Intrapulmonary Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Nebulized Administration of Laninamivir Octanoate in Healthy Japanese Subjects

H. Furuie, H. Ishizuka, K. Toyama, 2017, Antimicrobial Agents and Chemotherapy.

Intrapulmonary Distribution and Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Inhaled Administration of Its Prodrug, Laninamivir Octanoate, in Healthy Volunteers

H. Furuie, H. Ishizuka, K. Toyama, 2012, Antimicrobial Agents and Chemotherapy.

Intrapulmonary Pharmacokinetics of S-013420, a Novel Bicyclolide Antibacterial, in Healthy Japanese Subjects

J. Shimada, H. Furuie, T. Yoshikawa, 2009, Antimicrobial Agents and Chemotherapy.

Clinical Pharmacology Study of Drug Interaction between Fexofenadine Hydrochloride and Erythromycin

M. Okada, H. Furuie, A. Urae, 2000 .

Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP

K. Maeda, H. Kusuhara, Y. Sugiyama, 2012, British journal of pharmacology.

Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial

Y. Kumagai, Ichiro Oikawa, H. Furuie, 2018, British journal of clinical pharmacology.

Pharmacokinetics and Pharmacodynamics of Landiolol Hydrochloride, an Ultra Short-acting β1-Selective Blocker, in a Dose Escalation Regimen in Healthy Male Volunteers

H. Furuie, S. Irie, K. Matsuguma, 2005 .

Pharmacokinetics and Pharmacodynamics of Landiolol Hydrochloride , an Ultra Short-acting b 1-Selective Blocker , in a Dose Escalation Regimen in Healthy Male Volunteers

H. Furuie, S. Irie, K. Matsuguma, 2005 .

Absolute Bioavailability of Esaxerenone and Food Effects on its Pharmacokinetics After a Single Oral Dose in Healthy Japanese Subjects: An Open-Label Crossover Study

Takako Shimizu, H. Furuie, Manabu Kato, 2019, Advances in Therapy.

Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects

J. Shimada, H. Furuie, T. Katsube, 2019, The Journal of antimicrobial chemotherapy.

Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study

H. Fukase, T. Kajioka, Ichiro Oikawa, 2020, Clinical Drug Investigation.

Effects of Fexofenadine Hydrochloride on Psychomotor Performance

M. Okada, H. Furuie, A. Urae, 2000 .

Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects

Y. Sawada, H. Takanaga, S. Higuchi, 2000, Clinical pharmacology and therapeutics.

Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males

Takako Shimizu, H. Furuie, Manabu Kato, 2021, European Journal of Drug Metabolism and Pharmacokinetics.

Intrapulmonary pharmacokinetics of laninamivir in healthy subjects: Comparison between a nebulizer and a dry powder inhaler

H. Furuie, H. Ishizuka, K. Toyama, 2018, Respiratory infections.

Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.

K. Matsushita, H. Yotsuyanagi, H. Fukase, 2012, Vaccine.

Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid Antagonist

H. Furuie, H. Ishizuka, K. Toyama, 2017, Drugs in R&D.

Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects

T. Taguchi, H. Furuie, Manabu Kato, 2019, Clinical Drug Investigation.

Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)

R. Morishita, H. Nakagami, H. Furuie, 2023, Vaccines.

Safety and efficacy of AJG522 as a bowel cleansing agent for colonoscopy in healthy Japanese subjects

H. Furuie, M. Igarashi, F. Ueno, 2013 .